DELCATH SYSTEMS IN (DCTH)

0.31
0.01 2.64
OTC
Prev Close 0.30
Open 0.32
Day Low/High 0.29 / 0.32
52 Wk Low/High 0.00 / 10.30
Volume 18.93K
Exchange OTC
Shares Outstanding 9.02B
Market Cap 3.16M
Div & Yield N.A. (N.A)

Latest News

Delcath Issues Letter To Shareholders

Delcath Issues Letter To Shareholders

Delcath Announces Relisting On OTCQB

Delcath Announces Relisting On OTCQB

Company to Ensure Orderly Transition from NASDAQ to OTC Market

Delcath Issues Letter To Stockholders

Delcath Issues Letter To Stockholders

Delcath Issues Letter To Stockholders

Delcath Announces 2016 Financial Results

Delcath Announces Special Protocol Assessment Agreement With FDA For Pivotal Trial With Melphalan/HDS In Intrahepatic Cholangiocarcinoma

Company Plans to file 2016 Fourth Quarter and Year End Financial Results by March 30, 2017

Published Review Shows Delcath Investigational PHP Doubles Overall Survival Over Other Targeted Liver Therapies

Single-Center Retrospective Data Also Demonstrate Therapy Extends Progression-Free Survival by 9 Months

Analysis From Two Institutions Shows Strong Tumor Response, Overall Survival Potential Of Delcath Investigational PHP Therapy

Retrospective Analysis of Outcomes with Investigational Melphalan/HDS and Commercial CHEMOSAT® Projects Median Overall Survival to be 657 Days; 1,207 Days for Responders